MJR
@MJR_journal
MJR is an international, peer-reviewed platinum open access journal aims to publish innovative evidence-based articles in all fields of the rheumatic diseases.
🎉 Big milestone for the Mediterranean Journal of Rheumatology! We are proud to announce our first-ever Impact Factor: 1.4 (JCR 2024) 📊✨ This achievement reflects the dedication of our authors, reviewers, and editorial team — thank you for being part of this journey!
Check out the latest issue of MJR!! 🔹 Infrared Thermography in RMDs 🔹 Cortisol & RA outcomes 🔹 Anti-TIF1γ myositis 🔹 What do rheumatologists know about reproductive health? and much more!!
Exciting news for the MJR: The JCR 2024 Impact Factors are out! - mailchi.mp/mjrheum/jcr-im…
🆕 Physical modalities for #fibromyalgia pain relief 💡 Review highlights: 🔹 Exercise 🔹 Hydrotherapy 🔹 TENS 🔹 Low-level laser & magnetic therapy 📌 Safe non-pharma options for FM care 👉doi.org/10.31138/mjr.0…
📌 What happens when #Fibromyalgia meets #pregnancy? ✅ Symptom worsening (pain, anxiety, depression) ✅ Higher rates of gestational diabetes ✅ Mixed findings on neonatal outcomes (prematurity, low Apgar) Read more 👉doi.org/10.31138/mjr.2…
Starting #apremilast in #PsA? This new multicentre real-world study shows that baseline musculoskeletal #ultrasound helps select better responders, improving drug retention. 👉doi.org/10.31138/mjr.2…
🧡 World AS Day – 3 May 2025 #worldasday2025 Even simple tasks, like tying shoelaces, can be a challenge for those living with #axSpA We join the #LaceUpForAxSpA campaign and invite you to explore our special issue dedicated to axSpA 👉mjrheum.org/dec-2024-suppl3
🔥New Issue Alert! The March 2025 issue is out now! mjrheum.org In this issue: ✅Pregnancy & Fibromyalgia ✅HLA-DRB1* & Autoimmune Skin Disorders ✅ Physical modalities for Pain therapies in Fibromyalgia ✅AI in Autoimmunity ✅Diet & Inflammation & more
Only 48% of Greek patients with rheumatic diseases know what biosimilars are, and 81% want more info. 📊 Survey of 309 patients reveals major knowledge gaps and concerns about safety & efficacy. 🧠 Urgent need for patient education! doi.org/10.31138/mjr.1…
Oral Hyaluronic Acid in #Osteoarthritis & Low Back Pain 🔹 11 studies, 597 patients 🔹 80% showed improvement in pain & function 🔹 Safe, well-tolerated alternative to injections 👉doi.org/10.31138/mjr.2…
iTNFα vs. Newer Therapies in #SpA ✅ iTNFα inhibitors work across all SpA types ✅ IL-17i help #axSpA & #PsA but may worsen #IBD ✅ IL-12/IL-23i aid PsA & IBD but not axSpA ✅ JAKi show promise, but caution in elderly 👉doi.org/10.31138/mjr.0…
A new study on Anti-MDA5 Antibody-Associated RP-ILD ⚠️ High mortality risk—early intervention is key ✅ Early detection improves outcomes 📊 High ferritin & LDH predict poor prognosis 💊 Mixed results with combination therapy 👉doi.org/10.31138/mjr.0…
Atlantoaxial subluxation in #AxSpA 👉doi.org/10.31138/mjr.0… Rare but serious—watch for: 🔹 Persistent neck pain & stiffness 🔹 Limb weakness or numbness 🔹 Limited cervical motion ✅ MRI/CT > X-ray for diagnosis ✅ Surgery (C1-C2 fusion) often needed
📢MJR has been accepted for indexing by Emerging Sources Citation Index (Clarivate)👉bit.ly/4jCdgI6 The first Journal Impact Factor will be available next year. Congratulations to all contributors to this great achievement! 🎉
🔥New review on the Paradox of #Osteoporosis in #SpA👉rb.gy/jcqnya ✅ Prevalence and risk factors in #AxSpA & #PsA ✅ Impact of inflammatory cytokines (TNF, IL-17A) on bone loss ✅ Managing dual processes: new bone formation vs. bone loss
🔥 Special Issue of @MJR_journal on #Spondyloarthritis #SpA is here! 👉 rb.gy/pge9nm Featuring: ✅Challenging cases in #PsA & #AxSpA ✅TNFα inhibitors vs. novel therapies ✅The paradox of #osteoporosis in SpA ✅Highlights from #EULAR & #ACR congresses Stay updated!!
MJR: Special Issue on Spondylarthritides - mailchi.mp/ere/mjr-specia…
🔥A new review on D2M #axSpA 👉rb.gy/n4ptks 🩺The @Official_ASAS definition 📊20–28% prevalence in clinical settings 💡Key contributors: persistent inflammation, #comorbidity #fibromyalgia #depression & treatment resistance ✅Proposed strategies for tailored management
